Wile Balkhed

Publications

2026

Shan Cai, Christian Simonsson, Markus Karlsson, Wile Balkhed, Jens Tellman, Simone Ignatova, Patrik Nasr, Mattias Ekstedt, Stergios Kechagias, Wolf Bartholomä, Nils Dahlström, Peter Lundberg (2026)

Chronic Liver Disease: Assessing Inflammation and Fibrosis Using Three‐Dimensional MR Elastography With Same‐Day Biopsy in a Prospective Cohort Journal of Magnetic Resonance Imaging, Article jmri.70319 (Article in journal)

https://dx.doi.org/10.1002/jmri.70319

2025

Martin Bergram, Stergios Kechagias, Fredrik Iredahl, Wile Balkhed, Markus Holmberg, Nils Dahlström, Peter Lundberg, Patrik Nasr, Mattias Ekstedt, Karin Rådholm (2025)

Microvascular complications of type 2 diabetes with or without MASLD: the EPSOMIP study, a primary care cohort study BMC Primary Care, Vol. 26, Article 354 (Article in journal)

https://dx.doi.org/10.1186/s12875-025-03096-2

Wile Balkhed, Martin Bergram, Fredrik Iredahl, Markus Holmberg, Carl Edin, Carljohan Carlhäll, Tino Ebbers, Pontus Henriksson, Christian Simonsson, Karin Rådholm, Gunnar Cedersund, Mikael Forsgren, Olof Dahlqvist Leinhard, Cecilia Jönsson, Peter Lundberg, Stergios Kechagias, Nils Dahlström, Patrik Nasr, Mattias Ekstedt (2025)

Evaluating the prevalence and severity of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care Journal of Internal Medicine, Vol. 298, p. 173-187 (Article in journal)

https://dx.doi.org/10.1111/joim.20103

2023

Patrik Nasr, Mikael Forsgren, Wile Balkhed, Cecilia Jönsson, Nils Dahlström, Christian Simonsson, Shan Cai, Anna Cederborg, Martin Henriksson, Henrik Stjernman, Martin Rejler, Daniel Sjoegren, Gunnar Cedersund, Wolf Bartholomä, Ingvar Rydén, Peter Lundberg, Stergios Kechagias, Olof Dahlqvist Leinhard, Mattias Ekstedt (2023)

A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol BMC Gastroenterology, Vol. 23, Article 454 (Article in journal)

https://dx.doi.org/10.1186/s12876-023-03093-8

2022

Wile Balkhed, Fredrik O. Åberg, Patrik Nasr, Mattias Ekstedt, Stergios Kechagias (2022)

Repeated measurements of non-invasive fibrosis tests to monitor the progression of non-alcoholic fatty liver disease: A long-term follow-up study Liver international (Print), Vol. 42, p. 1546-1556 (Article in journal)

https://dx.doi.org/10.1111/liv.15255

News

Fatty liver – but not liver damage – common in type 2 diabetes

Six out of ten people with type 2 diabetes had fatty liver in a new study. Of these, only a small percentage had developed more severe liver disease. Type 2 diabetes in combination with obesity is linked to a greater risk.